Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sendurai A Mani

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
NPJ Breast Cancer|May 29, 2021
Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledgeGrace G Bushnell, Abhijeet P Deshmukh, Petra den Hollander, et al.
Cancers|April 14, 2025
β-Catenin Drives the FOXC2-Mediated Epithelial-Mesenchymal Transition and Acquisition of Stem Cell PropertiesMaria Castaneda, Petra den Hollander, Steve Werden, et al.
Cancer Research|January 31, 2016
Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane FluidityWeina Zhao, Sara Prijic, Bettina C Urban, et al.
Oncotarget|August 29, 2015
EMT-induced metabolite signature identifies poor clinical outcomeSalil Kumar Bhowmik, Esmeralda Ramirez-Peña, James Michael Arnold, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2007
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancersSendurai A Mani, Jing Yang, Mary Brooks, et al.
Cell|June 24, 2004
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasisJing Yang, Sendurai A Mani, Joana Liu Donaher, et al.
Cancer|September 20, 2013
Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cellsZhimin Tong, Subhankar Chakraborty, Bokyung Sung, et al.
European Journal of Medicinal Chemistry|August 24, 2022
Synthesis and biological evaluation of novel FiVe1 derivatives as potent and selective agents for the treatment of mesenchymal cancersFrancisco Martínez-Peña, Aaron D Pearson, Eileen L Tang, et al.
Journal of Mammary Gland Biology and Neoplasia|June 4, 2010
Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancerTony Blick, Honor Hugo, Edwin Widodo, et al.
Nature Communications|August 25, 2022
Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrencePatrick Aouad, Yueyun Zhang, Fabio De Martino, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
NPJ Breast Cancer|May 29, 2021
Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledgeGrace G Bushnell, Abhijeet P Deshmukh, Petra den Hollander, et al.
Cancers|April 14, 2025
β-Catenin Drives the FOXC2-Mediated Epithelial-Mesenchymal Transition and Acquisition of Stem Cell PropertiesMaria Castaneda, Petra den Hollander, Steve Werden, et al.
Cancer Research|January 31, 2016
Candidate Antimetastasis Drugs Suppress the Metastatic Capacity of Breast Cancer Cells by Reducing Membrane FluidityWeina Zhao, Sara Prijic, Bettina C Urban, et al.
Oncotarget|August 29, 2015
EMT-induced metabolite signature identifies poor clinical outcomeSalil Kumar Bhowmik, Esmeralda Ramirez-Peña, James Michael Arnold, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2007
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancersSendurai A Mani, Jing Yang, Mary Brooks, et al.
Cell|June 24, 2004
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasisJing Yang, Sendurai A Mani, Joana Liu Donaher, et al.
Cancer|September 20, 2013
Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cellsZhimin Tong, Subhankar Chakraborty, Bokyung Sung, et al.
European Journal of Medicinal Chemistry|August 24, 2022
Synthesis and biological evaluation of novel FiVe1 derivatives as potent and selective agents for the treatment of mesenchymal cancersFrancisco Martínez-Peña, Aaron D Pearson, Eileen L Tang, et al.
Journal of Mammary Gland Biology and Neoplasia|June 4, 2010
Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancerTony Blick, Honor Hugo, Edwin Widodo, et al.
Nature Communications|August 25, 2022
Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrencePatrick Aouad, Yueyun Zhang, Fabio De Martino, et al.
Pageof 11